Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT01868126 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma or Ocular Hypertension

Interventions

DRUG: DE-117 ophthalmic solution
DRUG: latanoprost ophthalmic solution
OTHER: Placebo

Sponsor

Santen Inc.